Quality of Life Assessment: Key Issues in the 1990sS.R. Walker, Rachel M. Rosser Springer Science & Business Media, 2012 M12 6 - 487 pages It was over five years ago that the Centre for Medicines Research organized a workshop entitled "Quality of Life: Assessment and Application". This workshop brought together a unique group of participants, some of whom had been involved in studies on quality of life for well over a decade, whilst others were meeting the subject for the first time. This blend of experienced researchers and enthusiastic newcomers was a great stimulus to the discus sions which followed individual presentations as well as that resulting from the study groups. In the ensuing publication, a balance was sought between a consideration of the complex principles underlying the assessment of quality of life and the application of such assessments to specific clinical conditions which necessitated this approach. The organization in 1991 of a second workshop entitled "Quality of Life Assessment: Key Issues in the 1990s" resulted in a further consideration of the quality of life philosophy, concepts and key instruments together with an update on assessing quality of life in a number of major disease areas. Of particular importance was an examination of various viewpoints concerned with ethical questions and their implications, and quality oflife from industry, regulatory and health care purchasers' perspectives. As a result of this second workshop, the editors of the original book referred to above decided to produce a second edition with a number of updates and additional chapters. |
From inside the book
Results 1-5 of 62
Page 4
... performance or activity measures in clinical studies, dating back to the venerable scales of both Karnofsky and Katz, or the disease-specific metrics promulgated by the New York Heart and the American Rheumatologic Associations. These ...
... performance or activity measures in clinical studies, dating back to the venerable scales of both Karnofsky and Katz, or the disease-specific metrics promulgated by the New York Heart and the American Rheumatologic Associations. These ...
Page 12
... performance, leisure time activities, and worries about health. Health outcomes are used to select treatments, for example, the results of clinical trials assessing the effects of different anti-hypertensive agents or anti-inflammatory ...
... performance, leisure time activities, and worries about health. Health outcomes are used to select treatments, for example, the results of clinical trials assessing the effects of different anti-hypertensive agents or anti-inflammatory ...
Page 15
... performance-based measures in which respondents are asked to do specific tasks. Their performance on these tasks ASSESSING FOR CLINICAL DECISION-MAKING 15.
... performance-based measures in which respondents are asked to do specific tasks. Their performance on these tasks ASSESSING FOR CLINICAL DECISION-MAKING 15.
Page 16
... Performance Activities of Daily Living/6 and functional vital signs!40 are examples of such direct measures of performance. Health examination data provide the means for obtaining unrecognized and undiagnosed conditions, including non ...
... Performance Activities of Daily Living/6 and functional vital signs!40 are examples of such direct measures of performance. Health examination data provide the means for obtaining unrecognized and undiagnosed conditions, including non ...
Page 22
... performance Psychological attitudes and behaviours including distress and well-being Alertness; disorientation; problems in reasoning Acute or chronic reduction in physical activity, mobility, self-care, sleep, communication Performance ...
... performance Psychological attitudes and behaviours including distress and well-being Alertness; disorientation; problems in reasoning Acute or chronic reduction in physical activity, mobility, self-care, sleep, communication Performance ...
Contents
11 | |
22 | |
rationale for a single | 65 |
Development testing and use of the Sickness Impact | 95 |
The Nottingham Health Profile | 111 |
an update | 131 |
A health index and output measure | 151 |
life 15D and its applications | 185 |
Measuring the quality of life of patients with Parkinsons | 289 |
Measuring quality of life in hypertension | 321 |
Measuring quality of life in psychiatry | 343 |
R B Joyce | 373 |
Industry perspectives on quality of life | 383 |
A regulatory view | 393 |
The cost effectiveness of pharmaceuticals | 401 |
Requirements for health care purchasers | 413 |
A WHO method for the assessment of healthrelated | 201 |
The OnLine Guide to QualityofLife Assessment | 221 |
Assessing Quality of Life in Major Disease Areas | 235 |
Measuring the quality of life of patients with rheumatoid | 269 |
The importance of quality of life in policy decisions | 427 |
Appendices | 441 |
Other editions - View all
Quality of Life Assessment: Key Issues in the 1990s S R Walker,Rachel M Rosser No preview available - 1992 |
Quality of Life Assessment: Key Issues in the 1990s S.R. Walker,Rachel M. Rosser No preview available - 2012 |
Common terms and phrases
ACE inhibitors activities airways disease analysis angina antihypertensive application areas Assessment of Quality asthma atenolol auranofin behaviour benefits Bergner cancer patients captopril chronic cilazapril clinical trials clinician compared comparison components concepts coronary correlation cost depression dimensions disability distress domains drug dysfunction effects evaluation example factors function scores groups health services health status measures health-related quality hospital hypertension illness impairment important improvement indicators individual instrument interventions interview investigator Kaplan levodopa measure of health measurement of quality medicine methodological methods methyldopa mobility morbidity mortality nifedipine outcome overall pain Parkinson's disease performance physical function population problems propranolol psychiatric psychological psychometric psychosocial QALY questionnaire reliability respiratory response rheumatoid arthritis Rosser self-administered sensitivity Sickness Impact Profile side-effects SIP score specific standard standard gamble statistical surgery symptoms Table tests therapy treatment validity valuation verapamil weights well-being well-years